AdaptHealth Corp (NASDAQ: AHCO)’s stock price has gone rise by 25.56 in comparison to its previous close of 8.55, however, the company has experienced a 22.83% increase in its stock price over the last five trading days. zacks.com reported 2025-02-25 that AdaptHealth Corp. (AHCO) came out with quarterly earnings of $0.39 per share, beating the Zacks Consensus Estimate of $0.29 per share. This compares to earnings of $0.64 per share a year ago.
Is It Worth Investing in AdaptHealth Corp (NASDAQ: AHCO) Right Now?
Moreover, the 36-month beta value for AHCO is 1.35. Analysts have varying opinions on the stock, with 5 analysts rating it as a “buy,” 1 as “overweight,” 3 as “hold,” and 0 as “sell.”
The public float for AHCO is 86.29M and currently, short sellers hold a 9.55% of that float. On February 25, 2025, AHCO’s average trading volume was 1.19M shares.
AHCO’s Market Performance
AHCO stock saw an increase of 22.83% in the past week, with a monthly gain of 3.92% and a quarterly increase of 10.44%. The volatility ratio for the week is 4.33%, and the volatility levels for the last 30 days are 4.23% for AdaptHealth Corp (AHCO). The simple moving average for the last 20 days is 12.07% for AHCO’s stock, with a simple moving average of 4.67% for the last 200 days.
Analysts’ Opinion of AHCO
Many brokerage firms have already submitted their reports for AHCO stocks, with Jefferies repeating the rating for AHCO by listing it as a “Hold.” The predicted price for AHCO in the upcoming period, according to Jefferies is $8 based on the research report published on January 08, 2024 of the previous year 2024.
BofA Securities, on the other hand, stated in their research note that they expect to see AHCO reach a price target of $6.50, previously predicting the price at $9.50. The rating they have provided for AHCO stocks is “Underperform” according to the report published on November 08th, 2023.
Stifel gave a rating of “Hold” to AHCO, setting the target price at $11 in the report published on May 10th of the previous year.
AHCO Trading at 9.18% from the 50-Day Moving Average
After a stumble in the market that brought AHCO to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -9.79% of loss for the given period.
Volatility was left at 4.23%, however, over the last 30 days, the volatility rate increased by 4.33%, as shares sank -1.77% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +13.57% upper at present.
During the last 5 trading sessions, AHCO rose by +23.97%, which changed the moving average for the period of 200-days by +11.01% in comparison to the 20-day moving average, which settled at $9.58. In addition, AdaptHealth Corp saw 12.76% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at AHCO starting from Rietkerk Shaw, who proposed sale 32,500 shares at the price of $9.70 back on Dec 19 ’24. After this action, Rietkerk Shaw now owns shares of AdaptHealth Corp, valued at $315,250 using the latest closing price.
Clemens Jason A, the Chief Financial Officer of AdaptHealth Corp, sale 35,000 shares at $9.35 during a trade that took place back on Dec 10 ’24, which means that Clemens Jason A is holding 420,719 shares at $327,250 based on the most recent closing price.
Stock Fundamentals for AHCO
Current profitability levels for the company are sitting at:
- 0.09 for the present operating margin
- 0.15 for the gross margin
The net margin for AdaptHealth Corp stands at -0.07. The total capital return value is set at 0.07. Equity return is now at value -13.42, with -4.74 for asset returns.
Based on AdaptHealth Corp (AHCO), the company’s capital structure generated 0.59 points at debt to capital in total, while cash flow to debt ratio is standing at 0.25. The debt to equity ratio resting at 1.44. The interest coverage ratio of the stock is 2.15.
Currently, EBITDA for the company is -171.09 million with net debt to EBITDA at 6.45. When we switch over and look at the enterprise to sales, we see a ratio of 1.08. The receivables turnover for the company is 8.13for trailing twelve months and the total asset turnover is 0.73. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.24.
Conclusion
To wrap up, the performance of AdaptHealth Corp (AHCO) has been better in recent times. The stock has received a bullish of “buy” and “hold” ratings from analysts. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
